Kobo Biotech Ltd — Quarterly Results & Earnings

₹2.23

+1.30%

Profit Growth YoY-8.13%Latest quarter

Sales Growth YoYN/ALatest quarter

Sales CAGR 5YN/A5 year compound

Profit CAGR 5Y12.21%5 year compound

📋

Quarterly Performance

YoY Profit Growth-8.13%

⚠️ Mild contraction

YoY Sales Growth+0.00%

⚠️ Mild contraction

OPM 5Y Average

Operating profit margin

N/A

EPS Growth 5Y

12.21%

Interest Coverage

Higher = safer debt servicing

N/A

ROE

N/A

ROCE

-52.90%

💡

Growth Analysis

Kobo Biotech Ltd reported YoY profit growth of -8.13% and revenue growth of N/A in the latest quarter. Mild profit contraction — investigate if one-time or structural. Over 5 years, sales compounded at N/A and profits at 12.21% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Kobo Biotech Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Commodity Chemicals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.